Aphria Increases Arizona Medical Cannabis Investment

Aphria Strengthens US Investment Platform, Increases Position in Copperstate Farms Investors to 18.5% Expanded investment increases Aphria’s position in robust Arizona medical cannabis market LEAMINGTON, ONTARIO–(Marketwired – March 27,...
- March 27th, 2017 at 8:19 am

Canopy San Diego Cannabis Accelerator Selects 8 Startups

Canopy San Diego Launches Spring Cohort of Cannabis Tech Companies Canopy San Diego, Southern California’s premier seed-stage accelerator program for technology and business infrastructure companies that support the legal...
- March 27th, 2017 at 8:10 am

Understanding Canadian Cannabis Reverse Takeovers

Cannabis RTOs/IPOs Guest post by Steven Looi and Michael Miller of Initiative Capital  On March 11th, 2016, Ontario based Supreme Pharmaceuticals Inc. (CSE: SL) issued a press release to indicate...
- March 24th, 2017 at 3:22 pm

Israeli Cannabinoid Biotech Therapix IPOs on NASDAQ

Therapix Biosciences Ltd. Announces Pricing of U.S. Initial Public Offering and NASDAQ Listing TEL AVIV, Israel, March 22, 2017 /PRNewswire/ — Therapix Biosciences Ltd. (NASDAQ: TRPX) (TASE: THXBY), a...
- March 22nd, 2017 at 3:14 pm

Aphria Graduates to Toronto Stock Exchange

Aphria Continues Success Story With TSX Listing Listing increases access to capital and growing investor base interested in burgeoning cannabis industry LEAMINGTON, ONTARIO–(Marketwired – March 21, 2017) – Aphria...
- March 21st, 2017 at 8:19 am

Emblem Exceeds 2000 Active Patients

Emblem Sees Significant Rise in Patient Acquisition PARIS, ONTARIO–(Marketwired – March 20, 2017) – Emblem Corp. (TSXV: EMC) (OTC: EMMBF) (“Emblem” or the “Company”) is pleased to announce that...
- March 20th, 2017 at 7:59 am

Nevada Medical Cannabis Patient Growth Bounces Back

After a two month pause in growth following the November elections, Nevada medical cannabis patient growth jumped by 4.1% in February to 26,519. This follows 0.3% growth in December...
- March 17th, 2017 at 11:43 am

Vyripharm Cannabis Testing Platform Issued Patent

Vyripharm Biopharmaceuticals Issued Patent for Comprehensive Medical Cannabis Testing from Agriculture to Clinical Applications Raising the Bar for Comprehensive Medical Cannabis and Hemp Testing and Evaluation HOUSTON, March 17,...
- March 17th, 2017 at 9:17 am